Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Crescent Enterprises is a UAE-based multinational conglomerate that invests in, incubates, and operates businesses across diverse sectors, with a growing focus on life sciences through its CE-Ventures platform. Its life science portfolio includes companies developing novel antibody-drug conjugates for oncology, microbiome-based immunotherapies for cancer and inflammatory diseases, and microbial immunotherapies for women’s reproductive health. These investments are at various stages of clinical development, from pre-clinical to Phase 2 trials.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Crescent Enterprises.